Navigation Links
Gypsum Wallboard from CertainTeed's Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R)
Date:5/19/2008

VALLEY FORGE, Pa., May 19 /PRNewswire/ -- The St. Jude Dream Home(R) in Hurricane, W. Va., is home to the first drywall ever manufactured at the new CertainTeed Gypsum Plant in nearby Moundsville, W. Va. To support the annual fundraiser for St. Jude Children's Research Hospital, CertainTeed is donating gypsum wallboard and roofing shingles that will be used in the house.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070102/CLTU053LOGO )

The 3,100 square foot St. Jude Dream Home, which will be auctioned as part of a fundraiser for the organization, will include 330 pieces of CertainTeed ProRoc(R) wallboard and feature approximately 60 squares of CertainTeed Landmark(TM) designer shingles. The donation is being made in conjunction with The Contractor Yard in Charleston, W. Va., who is assisting with the delivery of the materials.

"I cannot think of a better way to inaugurate the new Moundsville plant than through a contribution to this worthwhile, local project," says Peter Dachowski, President and CEO of CertainTeed Corporation. "We are thrilled to support the St. Jude Dream Home Giveaway with our quality roofing and wallboard products."

CertainTeed continues to focus on environmentally friendly products to enhance building sustainability and contribute to LEED(R) credits in green building design projects. All of ProRoc's face and back paper contain both pre- and post-consumer waste, with a recycled content of nearly 100 percent. Many CertainTeed roofing products are manufactured with pre- and post-consumer recycled content.

CertainTeed Gypsum offers a broad range of gypsum and finishing products for interior and exterior needs. This, in combination with the full range of CertainTeed building products, provides architects, contractors, builders and dealers one partner to provide service and support for commercial and residential building projects. CertainTeed operates 13 gypsum board plants and 12 roofing plants throughout North America.

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. The organization's fundraising efforts, such as the Dream Home Giveaway, help pay for children's medical care and treatment. For more information on the St. Jude Dream Home Giveaway, visit http://www.stjude.org.

About CertainTeed

Through innovation and creative product design, CertainTeed has helped shape the building products industry for more than 100 years. Founded in 1904 as General Roofing Company, the firm made its slogan "Quality Made Certain, Satisfaction Guaranteed," which quickly inspired the name CertainTeed. Today, CertainTeed is North America's leading brand of exterior and interior building products, including roofing, siding, windows, fence, decking, railing, trim, foundations, pipe, insulation, gypsum, ceilings and access covers.

Headquartered in Valley Forge, Pa., CertainTeed and its affiliates have more than 7,000 employees and more than 70 manufacturing facilities throughout the United States and Canada. In 2007 the group had consolidated sales of more than $3 billion. http://www.certainteed.com.

For more information contact:

Michael B. Loughery, CertainTeed

(610) 341-7328

mike.b.loughery@saint-gobain.com

http://www.certainteed.com/pressroom


'/>"/>
SOURCE CertainTeed
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Depression, PTSD Common Among Lung Transplant Patient Caregivers
2. Depression and PTSD symptoms in caregivers of lung transplant patients
3. Islet Cell Transplants Aid Type 1 Diabetics
4. New Guidelines Issued for Implanted Heart Devices
5. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
6. ISU researcher performs first veterinary corneal implant procedure in US
7. Beyond nutrition -- plants deliver
8. American Transplant Congress 2008
9. Study in mice suggests molecules in plants have beneficial effect on Alzheimers disease
10. Kidney Trouble Short-Lived in Most Liver Transplant Patients
11. Studies test new approaches to islet transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: